• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 15 个假基因的预后签名,用于预测乳腺癌的生存和抗肿瘤免疫反应。

Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.

机构信息

Department of Medical Bioinformatics, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.

Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou 510080, China.

出版信息

Aging (Albany NY). 2020 Dec 16;13(10):14499-14521. doi: 10.18632/aging.103735.

DOI:10.18632/aging.103735
PMID:33378744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8202842/
Abstract

Pseudogenes are noncoding RNAs that have been revealed to play critical roles in oncogenesis and tumor progression. However, their functional roles have not been comprehensively clarified in breast cancer. Here, we systematically analyzed the RNA sequencing data of 13931 pseudogenes in 775 breast cancer patients from The Cancer Genome Atlas dataset, and ultimately identified 15 prognostic pseudogenes by univariate Cox proportional hazard regression. A risk score model was constructed based on the prognostic pseudogenes via LASSO analysis and dichotomized patients into low- and high-risk subgroups. Patients in the high-risk group had a significantly shorter overall survival than those in the low-risk group. The prognostic value of these 15 pseudogenes and the risk score model were further validated in the European Genome-Phenome Archive dataset. Furthermore, we performed consensus clustering of the 15 prognostic pseudogenes and found that their expression pattern was significantly associated with tumor malignancy and host antitumor immune response, in terms of infiltrating immune cell compositions, antigen presenting genes expression, cytolytic activity and T-cell exhausted markers. This study indicated that these 15 prognostic pseudogenes were significantly correlated with tumor malignancy and host antitumor immune response in breast cancer, and might serve as potential targets for immunotherapy.

摘要

假基因是非编码 RNA,现已发现其在肿瘤发生和肿瘤进展中发挥关键作用。然而,其在乳腺癌中的功能作用尚未得到全面阐明。在这里,我们系统地分析了来自癌症基因组图谱数据集的 775 名乳腺癌患者的 13931 个假基因的 RNA 测序数据,并最终通过单因素 Cox 比例风险回归鉴定了 15 个预后假基因。通过 LASSO 分析构建了基于预后假基因的风险评分模型,并将患者分为低风险和高风险亚组。高风险组患者的总生存率明显低于低风险组患者。这些 15 个假基因和风险评分模型的预后价值在欧洲基因组-表型档案数据集进一步得到验证。此外,我们对 15 个预后假基因进行了共识聚类分析,发现它们的表达模式与肿瘤恶性程度和宿主抗肿瘤免疫反应显著相关,表现在浸润免疫细胞组成、抗原呈递基因表达、细胞毒性活性和 T 细胞耗竭标志物方面。这项研究表明,这些 15 个预后假基因与乳腺癌中的肿瘤恶性程度和宿主抗肿瘤免疫反应显著相关,可能成为免疫治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/2762fa8eefcd/aging-13-103735-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/d22a5e11526c/aging-13-103735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/906b51f898dc/aging-13-103735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/123530eaab16/aging-13-103735-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/c984cdb6ecb2/aging-13-103735-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/d95b90591ef6/aging-13-103735-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/2762fa8eefcd/aging-13-103735-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/d22a5e11526c/aging-13-103735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/906b51f898dc/aging-13-103735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/123530eaab16/aging-13-103735-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/c984cdb6ecb2/aging-13-103735-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/d95b90591ef6/aging-13-103735-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d5e/8202842/2762fa8eefcd/aging-13-103735-g006.jpg

相似文献

1
Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.基于 15 个假基因的预后签名,用于预测乳腺癌的生存和抗肿瘤免疫反应。
Aging (Albany NY). 2020 Dec 16;13(10):14499-14521. doi: 10.18632/aging.103735.
2
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.鉴定铁死亡相关基因特征在乳腺癌患者中的预后价值。
BMC Cancer. 2021 May 31;21(1):645. doi: 10.1186/s12885-021-08341-2.
3
An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.基于免疫细胞浸润的免疫评分模型预测乳腺癌的预后和化疗效果。
Theranostics. 2020 Oct 25;10(26):11938-11949. doi: 10.7150/thno.49451. eCollection 2020.
4
A novel immune-related prognostic index for predicting breast cancer overall survival.一种用于预测乳腺癌总生存期的新型免疫相关预后指数。
Breast Cancer. 2021 Mar;28(2):434-447. doi: 10.1007/s12282-020-01175-z. Epub 2020 Nov 4.
5
Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.基于免疫相关长链非编码 RNA 新型特征预测浸润性乳腺癌的免疫景观。
Cancer Med. 2021 Sep;10(18):6561-6575. doi: 10.1002/cam4.4189. Epub 2021 Aug 11.
6
Pseudogene-gene functional networks are prognostic of patient survival in breast cancer.假基因-基因功能网络可预测乳腺癌患者的生存情况。
BMC Med Genomics. 2020 Apr 3;13(Suppl 5):51. doi: 10.1186/s12920-020-0687-0.
7
A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.机器学习鉴定的四假基因分类器可作为骨肉瘤生存的新型预后标志物。
Genes (Basel). 2019 May 29;10(6):414. doi: 10.3390/genes10060414.
8
Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.机器学习在开发新型五假基因标志物预测头颈部鳞状细胞癌预后中的应用:生物医学实践中“垃圾基因”的新视角。
DNA Cell Biol. 2020 Apr;39(4):709-723. doi: 10.1089/dna.2019.5272. Epub 2020 Feb 11.
9
Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.鉴定五个与免疫相关的 lncRNAs,用于预测乳腺癌患者的生存和肿瘤微环境特征。
Comput Math Methods Med. 2021 Feb 27;2021:6676692. doi: 10.1155/2021/6676692. eCollection 2021.
10
Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.建立一种新的风险评分模型,通过全面分析膀胱癌免疫原数据库,以指示临床意义并预测预后。
Aging (Albany NY). 2020 Jun 22;12(12):11967-11989. doi: 10.18632/aging.103364.

引用本文的文献

1
KCNN4 as a genomic determinant of cytosolic delivery by the attenuated cationic lytic peptide L17E.KCNN4作为减毒阳离子溶细胞肽L17E进行胞质递送的基因组决定因素。
Mol Ther. 2025 Feb 5;33(2):595-614. doi: 10.1016/j.ymthe.2024.12.050. Epub 2025 Jan 1.
2
Somatic Copy Number Alterations in Colorectal Cancer Lead to a Differentially Expressed ceRNA Network (ceRNet).结直肠癌中的体细胞拷贝数改变导致差异表达的竞争性内源RNA网络(ceRNet)。
Curr Issues Mol Biol. 2023 Nov 28;45(12):9549-9565. doi: 10.3390/cimb45120597.
3
MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer.

本文引用的文献

1
Identification of a Five-Pseudogene Signature for Predicting Survival and Its ceRNA Network in Glioma.用于预测胶质瘤生存的五假基因特征及其ceRNA网络的鉴定
Front Oncol. 2019 Oct 15;9:1059. doi: 10.3389/fonc.2019.01059. eCollection 2019.
2
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers.分析化疗抵抗性三阴性乳腺癌复发的分子调控因子。
Breast Cancer Res. 2019 Aug 5;21(1):87. doi: 10.1186/s13058-019-1171-7.
3
A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
MLSP:一种用于预测乳腺癌患者分子亚型和预后的生物信息学工具。
Comput Struct Biotechnol J. 2022 Nov 11;20:6412-6426. doi: 10.1016/j.csbj.2022.11.017. eCollection 2022.
4
N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma.N6-甲基腺苷相关预后假基因有助于预测头颈部鳞状细胞癌的免疫治疗获益和治疗药物。
Theranostics. 2022 Oct 17;12(17):7267-7288. doi: 10.7150/thno.76689. eCollection 2022.
5
Immune-Related Genes to Construct a Novel Prognostic Model of Breast Cancer: A Chemosensitivity-Based Study.基于化疗敏感性构建免疫相关基因的乳腺癌新型预后模型:一项化疗敏感性研究。
Front Immunol. 2021 Oct 26;12:734745. doi: 10.3389/fimmu.2021.734745. eCollection 2021.
五个假基因的预后特征可预测低级别胶质瘤。
Biomed Pharmacother. 2019 Sep;117:109116. doi: 10.1016/j.biopha.2019.109116. Epub 2019 Jun 24.
4
CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.CD137 通过增强单核细胞/巨噬细胞的迁移和破骨细胞分化促进乳腺癌骨转移。
Theranostics. 2019 May 9;9(10):2950-2966. doi: 10.7150/thno.29617. eCollection 2019.
5
Mechanisms of immune-related adverse events associated with immune checkpoint blockade: using germline genetics to develop a personalized approach.免疫检查点阻断相关免疫相关不良事件的机制:利用种系遗传学制定个体化方法。
Genome Med. 2019 Jun 20;11(1):39. doi: 10.1186/s13073-019-0652-8.
6
Identification of a lncRNA‑associated competing endogenous RNA‑regulated network in clear cell renal cell carcinoma.鉴定肾透明细胞癌中 lncRNA 相关竞争性内源 RNA 调控网络。
Mol Med Rep. 2019 Jul;20(1):485-494. doi: 10.3892/mmr.2019.10290. Epub 2019 May 23.
7
PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers.伪 FuN:从 32 种癌症中与基因和 microRNAs 的整合关系中推导出假基因的功能潜力。
Gigascience. 2019 May 1;8(5). doi: 10.1093/gigascience/giz046.
8
Tumor Heterogeneity Correlates with Less Immune Response and Worse Survival in Breast Cancer Patients.肿瘤异质性与乳腺癌患者免疫反应减弱和预后不良相关。
Ann Surg Oncol. 2019 Jul;26(7):2191-2199. doi: 10.1245/s10434-019-07338-3. Epub 2019 Apr 8.
9
Pseudogenes Provide Evolutionary Evidence for the Competitive Endogenous RNA Hypothesis.假基因为竞争性内源性 RNA 假说提供了进化证据。
Mol Biol Evol. 2018 Dec 1;35(12):2886-2899. doi: 10.1093/molbev/msy183.
10
Role of Pseudogenes in Tumorigenesis.假基因在肿瘤发生中的作用。
Cancers (Basel). 2018 Aug 1;10(8):256. doi: 10.3390/cancers10080256.